Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000074900 | SCV000108113 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Eurofins Ntd Llc |
RCV000202013 | SCV000859445 | benign | not specified | 2018-01-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001520265 | SCV001729326 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001709479 | SCV001938806 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28874130, 28932927) |
KCCC/NGS Laboratory, |
RCV003315589 | SCV004015971 | benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000202013 | SCV004233072 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 75% of patients studied by a panel of primary immunodeficiencies. Number of patients: 71. Only high quality variants are reported. |
Mayo Clinic Laboratories, |
RCV000202013 | SCV000257267 | benign | not specified | no assertion criteria provided | research | ||
Clinical Genetics Laboratory, |
RCV000202013 | SCV001906116 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000202013 | SCV001956167 | benign | not specified | no assertion criteria provided | clinical testing |